Concepedia

Nicolás M. S. Gálvez

NM

16

Publications

591

Citations

13

H-Index

2018

Active since

Affiliations

Millennium Institute on Immunology and Immunotherapy(Current)

Pontificia Universidad Católica de Chile

Instituto de Salud Pública de Chile

Sinovac Biotech

La Jolla Institute for Immunology

Nicolás M. S. Gálvez is an author at Millennium Institute on Immunology and Immunotherapy specializing in cell transplantation, vaccine development, and transplantation.

ORCID

Top concepts

Publications per year

2018–2023

16

Publications

16

Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile

Susan M. Bueno, Katia Abarca, Pablo A. González et al. · Clinical Infectious Diseases · 2021 · 109 citations · Full text

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine

Felipe Melo-González, Jorge A. Soto, Liliana A González et al. · Frontiers in Immunology · 2021 · 80 citations · Full text

Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine

Luisa F. Duarte, Nicolás M. S. Gálvez, Carolina Iturriaga et al. · Frontiers in Immunology · 2021 · 67 citations · Full text

Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial

Susan M. Bueno, Katia Abarca, Pablo A. González et al. · 2021 · 59 citations · Full text

Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial

Katia Abarca, Emma Rey-Jurado, Natalia Muñoz‐Durango et al. · EClinicalMedicine · 2020 · 54 citations · Full text

Rows per page

1–5 of 16